i'? Drug development: Sprint finish
L Drew - Nature, 2017 - go.gale.com
L Drew
Nature, 2017•go.gale.comi'?Drug development: Sprint finish - Document - Gale Academic OneFile Use this link to get
back to this page. Copy Skip to Content Library Menu: Google Scholar Discovery Partner
English Select Language English Afrikaans العربية Bahasa Indonesia Bahasa Malaysia česky
Cymraeg Dansk Deutsch English Español Français Gaeilge Hrvatski Italiano magyar ខ្មែរ
Nederlands Polski Português Română Slovenščina slovenský suomi svenska Tagalog Tiếng
Việt Türkçe Русский Ελληνικά বাংলা हिंदी தமிழ் ไทย 中文(简体) 中文(繁體) 日本語 …
back to this page. Copy Skip to Content Library Menu: Google Scholar Discovery Partner
English Select Language English Afrikaans العربية Bahasa Indonesia Bahasa Malaysia česky
Cymraeg Dansk Deutsch English Español Français Gaeilge Hrvatski Italiano magyar ខ្មែរ
Nederlands Polski Português Română Slovenščina slovenský suomi svenska Tagalog Tiếng
Việt Türkçe Русский Ελληνικά বাংলা हिंदी தமிழ் ไทย 中文(简体) 中文(繁體) 日本語 …
Abstract
Biotechnology start-ups and pharmaceutical giants alike are charging ahead to develop therapies for the most serious form of non-alcoholic fatty liver disease.
Gale